Every finding on record at Heart of Hope Asian American Hospice Care, A Nonprofit Corporation

It is required that the documented comprehensive assessment includes a drug profile that contains the patient's current: Prescription and over-the-counter (OTC) drugs; The drug profile is updated per the hospice policy and procedure, but, at minimum, at the time of each comprehensive assessment and/or when new medication is added or changes are made to existing medication. This standard was not met as evidenced by clinical record review and interview. In 1 of 3 (33%) home visits the agency did not ensure that the hospice medication profile was reconciled with each comprehensive assessment and updated with when new medication was added. CLINICAL RECORD 1: The patient elected hospice on 11/18/2025 with a diagnosis of Alzheimer's disease. During the home visit (HV1) with the registered nurse (personnel record 6) on 01/09/2026, the facility medication profile printed on 01/09/2026 documented, on 12/15/2025, "Guaifenesin oral syrup 100mg/5ml, give 10ml by mouth every 8 hours as needed for cough." The hospice medication profile printed 01/09/2026 did not include Guaifenesin. The registered nurse questioned the facility medication nurse who verified that the order was written on 12/15/2025 by the Nurse practitioner at the facility. During an interview on 01/09/2026, the director of patient care services reviewed the hospice medication profile and verified the medication was not entered onto the hospice medication profile as she had not been informed by the facility of the new medication order. She stated that this should have been discovered when reconciling medication records during the comprehensive assessment visit by the registered nurse.